New approach offered to treating cocaine addiction
Thursday, February 11, 2016 - 10:50
in Health & Medicine
An FDA-approved drug used for diabetes and obesity may also reduce cocaine dependence, new research indicates. The drug, trade name Byetta, derives from a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which regulates feeding behavior. Knowing what they did about GLP-1, the research team turned to it as a possible treatment for cocaine addicts.